Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neurology

Symptoms and Disease Behavior

At a Glance

MICU1-related MPXPS most often causes weakness and fatigue in the hips, shoulders, and thighs, while movement, learning, speech, vision, and skeletal changes vary. Symptoms usually begin in early childhood, but severity and progression can differ greatly, even among siblings.

Because MICU1-related MPXPS is so rare, the way it looks can vary significantly from one individual to another. Understanding the reported range of symptoms can help you work with your care team to address your child’s specific needs. While the name highlights muscle and movement symptoms, this condition can affect several different body systems.

Muscle Weakness and Fatigue

The most consistent feature of this condition is myopathy (muscle disease). This usually presents as weakness in the proximal muscles—the large muscles closest to the center of the body, like the hips, shoulders, and thighs [1][2].

  • Limb-Girdle Weakness: This is a pattern where the muscles of the hips and shoulders are weaker than the hands or feet. You might notice your child has trouble climbing stairs, getting up from the floor, or lifting their arms above their head [2].
  • Easy Fatigability: Most children with this condition experience significant fatigue. They may tire very quickly during normal play, walking, or school activities [3][2].
  • Persistent CK Elevation: Blood work will typically show high levels of creatine kinase (CK), which indicates that the muscle cells are under stress [3][4].
  • Severe Weakness Episodes: While most have steady weakness, a small number of reported cases describe sudden, severe episodes of muscle weakness that can last for hours or days. This is rare and not a universal feature of the disease [5].

Brain and Movement Signs

Movement and coordination issues are a defining part of the disorder’s name, but they are highly variable. About half of the children documented in small research cohorts developed these signs, while others never do [5][1].

  • Extrapyramidal Signs: These refer to involuntary movements originating from specific pathways in the brain. They can include chorea (jerky, “dance-like” involuntary movements) or dystonia (involuntary muscle contractions causing unusual postures) [6][7].
  • Ataxia: Distinct from extrapyramidal signs, ataxia is a coordination problem often linked to the cerebellum. A child with ataxia may have a shaky, clumsy, or unsteady gait (way of walking) [7][8].

Development and Learning

Many children with MICU1 deficiency will need extra support in school and with communication. Small referral-based cohorts report high rates of cognitive and speech involvement, though severity varies widely.

  • Learning Difficulties: A majority of reported children experience some form of learning difficulty, which can range from mild learning differences to intellectual disability [1].
  • Speech Impairment: Speech delays or difficulty pronouncing words clearly are commonly reported [1][3]. This is distinct from swallowing difficulty (dysphagia), which requires its own specific evaluation if you notice coughing during meals.

Vision and Bone Health

Other body systems are occasionally involved, though these findings are not present in every child:

  • Ocular (Eye) Findings: Occasional reports note ptosis (droopy eyelids), nystagmus (involuntary, rhythmic eye movements), or in rare instances, early-onset cataracts or reduced visual acuity [3][4][9].
  • Skeletal Findings: Some children develop physical changes such as pes planus (flat feet), hyperkyphosis (an exaggerated rounding of the upper back), or very flexible, hyperextensible joints [10][9][4].

How Symptoms Change Over Time

The age when symptoms first appear is typically in early childhood, but the diagnosis is often delayed for years due to the rarity of the disease [1]. Furthermore, even within the same family, siblings with the exact same genetic variants can have very different experiences. One sibling might have significant movement issues and learning delays, while another might only have mild muscle fatigue and high CK levels [10][1]. Because long-term natural history data is limited, individual disease trajectories remain difficult to predict [5][1].

Common questions in this guide

What symptoms are most common in MICU1-related MPXPS?
Children most often have weakness in the muscles near the hips and shoulders and tire easily. Blood tests commonly show high creatine kinase, or CK. Some children also have movement, learning, speech, eye, or skeletal changes, but the combination and severity of symptoms vary widely.
What does proximal muscle weakness look like in a child?
A child may have trouble climbing stairs, getting up from the floor, walking for long periods, or lifting their arms overhead. Weakness is often greater in the hips, shoulders, and thighs than in the hands and feet.
Do all children with MICU1-related MPXPS develop involuntary movements?
No. In small reported groups, about half of children developed movement signs, while others did not. Signs may include jerky movements, sustained unusual postures, or unsteady coordination.
Can MICU1-related MPXPS affect learning and speech?
Yes. Reported children may have learning difficulties ranging from mild differences to intellectual disability, along with delayed or unclear speech. Speech concerns are separate from swallowing problems, so coughing during meals should prompt a specific evaluation.
How does MICU1-related MPXPS change over time?
Symptoms often begin in early childhood, but diagnosis may take years because the condition is rare. Severity and the combination of symptoms can differ even between siblings with the same genetic variants. Because long-term information is limited, an individual child's course is difficult to predict.
What other health assessments may a child with MPXPS need?
Depending on symptoms, the care team may consider speech, swallowing, cognitive, eye, orthopedic, and physical therapy assessments. Some children develop eye findings or skeletal changes, but not every child needs the same schedule of monitoring. Ask the child's clinicians which evaluations fit their needs.

Get notified when new evidence is published on Proximal myopathy with extrapyramidal signs.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Bi-Allelic Variants in MICU1 Cause Myopathy With Extrapyramidal Signs: Case Series, Phenotypic Spectrum, and Genotype-Phenotype Correlations From 61 Patients.

    Beheshti P, Akbarian F, Esmaeilzadeh E, et al.

    Clinical genetics 2026; (109(3)):564-570 doi:10.1111/cge.70062.

    PMID: 40898676
  2. 2

    MICU1 related myopathy - a rare report from India.

    Baskar D, Ganji SR, Thomas A, et al.

    Journal of neuromuscular diseases 2024; (11(6)):1295-1299 doi:10.1177/22143602241288400.

    PMID: 39973469
  3. 3

    A Middle Eastern Founder Mutation Expands the Genotypic and Phenotypic Spectrum of Mitochondrial MICU1 Deficiency: A Report of 13 Patients.

    Musa S, Eyaid W, Kamer K, et al.

    JIMD reports 2019; (43()):79-83 doi:10.1007/8904_2018_107.

    PMID: 29721912
  4. 4

    Novel Homozygous Mitochondrial Calcium Uptake Protein 1 Variant (c.38T>C, p.Leu13Pro) in a 7-year-old Girl with Congenital Ptosis and Proximal Myopathy: Expanding the Phenotypic Spectrum.

    Lakshmi P, Chalipat S, Kunchepu M, Mane S

    Annals of African medicine 2026; (25(Suppl 4)):S717-S721 doi:10.4103/aam.aam_493_26.

    PMID: 42459038
  5. 5

    Case report: Unusual episodic myopathy in a patient with novel homozygous deletion of first coding exon of MICU1 gene.

    Sharova M, Skoblov M, Dadali E, et al.

    Frontiers in neurology 2022; (13()):1008937 doi:10.3389/fneur.2022.1008937.

    PMID: 36425804
  6. 6

    Mitochondrial Calcium Uptake 1 (MICU1) Gene-Related Myopathy with Extrapyramidal Signs: A Clinico-Radiological Case Report from India.

    Mukherjee D, Mukherjee A, Gupta S, et al.

    Annals of Indian Academy of Neurology 2023; (26(1)):73-75 doi:10.4103/aian.aian_904_22.

    PMID: 37034047
  7. 7

    Identification of a novel MICU1 nonsense variant causes myopathy with extrapyramidal signs in an Iranian consanguineous family.

    Bitarafan F, Khodaeian M, Amjadi Sardehaei E, et al.

    Molecular and cellular pediatrics 2021; (8(1)):6 doi:10.1186/s40348-021-00116-w.

    PMID: 33969448
  8. 8

    Molecular pathophysiology of human MICU1 deficiency.

    Kohlschmidt N, Elbracht M, Czech A, et al.

    Neuropathology and applied neurobiology 2021; (47(6)):840-855 doi:10.1111/nan.12694.

    PMID: 33428302
  9. 9

    Dolichocephaly, Arachnodactyly, Diplopia, and Distal Myopathy - Novel Phenotype of MICU1 Variant c.553C>T.

    Finsterer J, Barwari A

    Cureus 2024; (16(1)):e52672 doi:10.7759/cureus.52672.

    PMID: 38380193
  10. 10

    Compound heterozygous mutations in MICU1 cause myopathy with extrapyramidal signs in two Chinese pedigrees.

    Li J, Liu H, Gan X, et al.

    Frontiers in neurology 2025; (16()):1624830 doi:10.3389/fneur.2025.1624830.

    PMID: 41018190

This page is for informational purposes only and does not constitute medical advice. Your child's neuromuscular and developmental care team can interpret symptoms and recommend individualized assessments.